A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

By Out Henk J.  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment

By Popovic‐Todorovic B.  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2275-2282

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation

By Out HJ  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 622-627

Oxford University Press

Access to resources Recommend Favorite

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)

By Safdarian Leili   Mohammadi Farnoosh Soltani   Alleyassin Ashraf   Aghahosseini Marzieh   Meysamie Alipasha   Rahimi Eiman  

Human Reproduction, Vol. 22, Iss. 9, 2007-09 ,pp. : 2449-2454

Oxford University Press

Access to resources Recommend Favorite

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial

By Kamischke A  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 596-603

Oxford University Press

Access to resources Recommend Favorite